Charles River Laboratories’ $875 Million Acquisition of Cognate BioServices

Davis Polk and Hannes Snellman advised Charles River Laboratories International on the deal. Weil, Gotshal & Manges advised Charles River Laboratories on the antitrust aspects of the transaction.Charles River Laboratories International, Inc. completed its $875 million acquisition of Cognate BioServices, Inc. The transaction is expected to close by the end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions.

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.

Cognate is a dynamic, results-driven organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advanced cell therapy companies.

The Davis Polk corporate team advising Charles River included partner Michael Davis (Picture) and associates Matthew J. Cowcher and Mari Foster. The executive compensation team included partner Kyoko Takahashi Lin and associate Tessa Patti. The tax team included partner William A. Curran and associate Liang Zhang. Partner David R. Bauer and associate Hilary Smith provided intellectual property advice. Associate Michael Comstock provided environmental advice.

The Hannes Snellman’s core team included Richard Åkerman, Nicole Jerad, Douglas Essehorn, Iiris Ikkelä, and Alexander Lindqvist, Jenny Lundberg, and Elisabeth Vestin and Itai Coleman.

Weil’s Antitrust team was led by of global Antitrust/Competition practice Head Steven Newborn and partners Brianne Kucerik and Vadim Brusser (in Washington, D.C.), and included counsel Nafees Saeed (London) and associates Kristin Sanford and Alexandra Ampudia (Washington, D.C.).

Involved fees earner: David Bauer – Davis Polk & Wardwell; Michael Comstock – Davis Polk & Wardwell; Matthew Cowcher – Davis Polk & Wardwell; William Curran – Davis Polk & Wardwell; Michael Davis – Davis Polk & Wardwell; Mari Foster – Davis Polk & Wardwell; Tessa Patti – Davis Polk & Wardwell; Hilary Smith – Davis Polk & Wardwell; Kyoko Takahashi Lin – Davis Polk & Wardwell; Liang Zhang – Davis Polk & Wardwell; Richard Åkerman – Hannes Snellman; Itai Coleman – Hannes Snellman; Douglas Essehorn – Hannes Snellman; Iiris Ikkelä – Hannes Snellman; Nicole Jerad – Hannes Snellman; Alexander Lindqvist – Hannes Snellman; Jenny Lundberg – Hannes Snellman; Elisabeth Vestin – Hannes Snellman; Alexandra Ampudia – Weil, Gotshal & Manges; Vadim Brusser – Weil, Gotshal & Manges; Brianne Kucerik – Weil, Gotshal & Manges; Steven Newborn – Weil, Gotshal & Manges; Nafees Saeed – Weil, Gotshal & Manges; Kristin Sanford – Weil, Gotshal & Manges;

Law Firms: Davis Polk & Wardwell; Hannes Snellman; Weil, Gotshal & Manges;

Clients: Charles River Laboratories;

Martina Bellini

Author: Martina Bellini